Induction and Consolidation With Fludarabine, Cytarabine, Idarubicin, and Venetoclax for the Treatment of Acute Myeloid Leukemia
Clinical trial NCT07228273 · RECRUITING
Trial details
- NCT number
- NCT07228273
- Sponsor
- OHSU Knight Cancer Institute
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-12-12
- Primary completion
- 2029-06-24
- Enrollment
- 102
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.